According to latest data from National cancer registry, the estimated number of incident cases of cancer in India in 2022 was ...
Doctors at AIIMS, Delhi are developing a low-cost, antibody-based adaptive cellular therapy targeting multiple myeloma, a ...
Novel vaccine platform improved protection against diverse influenza subtypes when tested in animal models and human ...
Stitching together four molecules found in the standard flu vaccine ensures an immune response to all of them, Stanford Medicine scientists have shown.
The TRACeR I platform was incorporated into a humanized antibody fragment in a bispecific T-cell engager (BiTE) format. When ...
Objective: To comprehensively understand the infection status of human T-lymphotropic virus (HTLV) among the voluntary blood ...
Northwestern Medicine scientists have developed a method for identifying reactive cysteines on peptide antigens within the ...
A novel nanobody-based immunosensor, designed to function stably in undiluted biological fluids and harsh conditions, has ...
Favourable safety profile for world’s first LAG-3 agonist, IMP761, with no treatment related adverse events to dateAdditional safety data and ...
The lack of acute myeloid leukemia-specific antigens is one of the challenges for targeted immunotherapy together with on-target off-tumor toxicities due to the expression of the target in normal ...
OmniAb, Inc. (NASDAQ: OABI) today announced that two presentations featuring the Company's technologies were delivered at the 2024 Antibody Engineering & Therapeutics Conference (AETC) underway in San ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback